Evidence map›Paper›PMID 39362932›Full record

ArticleScientific reports2024

Structure-function analysis of time-resolved immunological phases in metabolic dysfunction-associated fatty liver disease (MASH) comparing the NIF mouse model to human MASH.

Anja Schmidt-Christensen, Gustaw Eriksson, William M Laprade, Behnaz Pirzamanbein, Maria Hörnberg, Kajsa Linde, Julia Nilsson, Mark Skarsfeldt, Diana J Leeming, Rajmund Mokso and 7 more

Abstract readComparative Study
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Targeting mTOR with vistusertib attenuates metabolic steatohepatitis and prevents HCC development.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  2. Review
  3. Review
  4. Flavonoid-Rich Extracts from Chuju (Foods (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Anja Schmidt-ChristensenLund University Diabetes Center, Lund University, Lund, Sweden.
Gustaw ErikssonDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
William M LapradeTechnical University of Denmark, DTU, Copenhagen, Denmark.
Behnaz PirzamanbeinTechnical University of Denmark, DTU, Copenhagen, Denmark.
Maria HörnbergInficure Bio AB, Umeå, Sweden.
Kajsa LindeInficure Bio AB, Umeå, Sweden.
Julia NilssonLund University Diabetes Center, Lund University, Lund, Sweden.
Mark SkarsfeldtNordic Bioscience A/S, Herlev, Denmark.
Diana J LeemingNordic Bioscience A/S, Herlev, Denmark.
Rajmund MoksoMAXIV laboratory, Lund University, Lund, Sweden.
Mariana VerezhakPaul Scherrer Institut, Villigen, Switzerland.
Anders DahlTechnical University of Denmark, DTU, Copenhagen, Denmark.
Vedrana DahlTechnical University of Denmark, DTU, Copenhagen, Denmark.
Kristina ÖnnerhagSkåne hospital, Malmö, Sweden.
Massoud Rezaee OghaziConnected Pathology, Lier, Belgium.
Sofia MayansInficure Bio AB, Umeå, Sweden.
Dan HolmbergLund University Diabetes Center, Lund University, Lund, Sweden. Dan.holmberg@umu.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic dysfunction-associated steatohepatitis (MASH) is a common but frequently unrecognized complication of obesity and type 2 diabetes. The association between these conditions is multifaceted and involves complex interactions between metabolic, inflammatory, and genetic factors. Here we assess the underlying structural and molecular processes focusing on the immunological phase of MASH in the nonobese inflammation and fibrosis (NIF) mouse model and compare it to the human disease as well as other murine models. Histopathology together with synchrotron-radiation-based x-ray micro-computed tomography (SRµCT) was used to investigate structural changes within the hepatic sinusoids network in the NIF mouse in comparison to patients with different severities of MASH. A time-course, bulk RNA-sequencing analysis of liver tissue from NIF mice was performed to identify the dynamics of key processes associated with the pathogenesis. Transcriptomics profiling of the NIF mouse revealed a gradual transition from an initially reactive inflammatory response to a regenerative, pro-fibrotic inflammatory response suggesting new avenues for treatment strategies that focus on immunological targets. Despite the lack of metabolic stress induced liver phenotype, a large similarity between the NIF mouse and the immunological phase of human MASH was detected. The translational value was further supported by the comparative analyses with MASH patients and additional animal models. Finally, the impact of diets known to induce metabolic stress, was explored in the NIF mouse. An obesogenic diet was found to induce key physiological, metabolic, and histologic changes akin to those observed in human MASH.

Indexed as

Disease Models, AnimalAnimalsDiabetes Mellitus, Type 2Fatty LiverHumansInflammationLiverMaleMiceMice, Inbred C57BLNon-alcoholic Fatty Liver DiseaseObesityX-Ray Microtomography

Identifiers

PMID39362932
PMCPMC11452201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.